BenzingaOctober 29, 2026 at 2:22 AM NY12 Days Ago
HC Wainwright & Co. Reiterates Buy on Tango Therapeutics, Maintains $68 Price Target
HC Wainwright & Co. analyst Robert Burns reiterates Tango Therapeutics (NASDAQ:TNGX) with a Buy and maintains $68 price target.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
